Merck Presents Phase IIb Study Results at AHA Annual Scientific Sessions

Merck Presents Phase IIb Study Results at AHA Annual Scientific Sessions
Trading Markets - 41 minutes ago
Nov 21, 2009 (Close-Up Media via COMTEX) -- MRK -- In a phase IIb study in 589 patients with primary hypercholesterolemia or mixed hyperlipidemia treated with anacetrapib as monotherapy or co ...